Ebersbach, Germany · Founded 2017 · Privately Held (backing)
Producer and supplier of cannabis intended to be used for medicinal drug research and development process. Demecan is based in Ebersbach, Germany and was founded in 2017. Its last known valuation is $109 million. It has raised $23.4 million.
Last price · $/share
—
Implied valuation
$108.8M
Total raised
$23.4M
Last round
—
Cap table — not yet on record
Demecan's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Demecan with a free account
·Watch Demecan: the Monday email on marks, rounds and moves
